Abstract:Wereporthereonoureffortstodevelopnewstrategiesforthesynthesisofa-tocopherol,thebiologicallymostsignificantmemberofthevitaminEfamily.Thisreviewcomprisesfivenewmethodstogeneratethechiral chromaneofa-tocopherolwithoverallupto29%yieldfromcommerciallyavailablematerialandupto94%de.
Introduction
Vitamin E comprises tocopherols 1-4 and tocotrienols 5-8 which can be isolated from all photosynthetic organisms (Fig. 1 ). These compounds exhibit various physiologically significant properties such as the modulation of signal transduction, [1] antiinflammatory action [2] and antioxidant reactivity. [3] a-Tocopherol (1) is the biologically most important member of the vitamin E family as it acts as the best radical chainbreaking antioxidant in tissues [4] and binds selectively to a transport protein [5] providing efficient bioavailability. The antioxidant reactivity of the chromanol system has been investigated in detail [3] and is attributed to stereoelectronic factors, i.e. the lone pair of O(1) is favorably oriented to stabilize the tocopheryl radical 9 produced by homolysis of the phenolic OH group (Scheme 1).
The isolation of pure 1 from natural sources is quite difficult because the compound appears in various amounts along with other vitamin E chromanols.
The challenge to prepare chiral 1 results from the presence of stereogenic centers at C(2), C(4'), and C(8'). A comprehensive review by Netscher describes the syntheses of racemic and enantiomerically enriched tocopherols up to 2006. [6] Since then we have developed several new approaches to chiral chromanols that are reviewed here.
Results and Discussion

Biomimetic Synthesis of a-
Tocopherol and a-Tocotrienol
The discovery of the enzyme tocopherol cyclase from Cyanobacteria [7] and investigations of the substrate specificity [8] and reaction mechanism [9] revealed that i) the enzyme cyclizes hydroquinone precursors with chiral and unsaturated side chains leading to 2 and 6, respectively, with the comparable efficiency; and ii) the very hydrophobic 42 kD protein operates by si protonation of the double bond and concomitant re attack of the phenol (Scheme 2).
In view of the weak acidity of amino acids available in the active site of the protein it was suggested [10] that substrates such as 10 bind to the enzyme in a high energy conformation (Scheme 2) in which both phenol and proton source are in binding distance of the double bond. This insight led to a biomimetic synthesis of a-tocopherol (1) using a large protecting group R and a dipeptide as steric constraints to generate a suitable conformation of the hydroquinone and providing a proton source, [11] see 11 (Scheme 3).
The general strategy to obtain a suitable precursor for cyclization to the chromanol system of vitamin E is outlined in Fig. 2 . It was anticipated that cyclization would proceed with the chiral side chain leading directly to 1 as well as with the unsaturated side chain yielding a-tocotrienol (5) that could be enantioselectively hydrogenated to 1 using established methods. [11] Accordingly, the synthesis of 1 started with the monoprotected hydroquionone 13 which underwent a Mannich reaction with the proline derivative 14 (Scheme 4). [12] Subsequent esterification with camphanoyl chloride and deprotection gave 15 to which the protected aspartate 16 was added. The resulting phytyl phenol 17 was cyclized in the presence of pTsOH and furnished the protected chromanol dipeptide 18 in excellent yield. The benzylic amine of 18 was removed by hydrogenation and the (2R,4'R,8'R)-tocopherylester 19a obtained displaying 70% de (diasteromeric excess). Systematic investigation of the cyclization reaction revealed that i) the de is independent of the camphanoyl unit (useful for de determination of the final product), ii) the de depends on the chirality of the dipeptide. For example if (S)-proline/(S)-aspartate were employed the (2S,4'R,8'R)-tocopheryl camphanate was obtained displaying 80% de. A similar reaction sequence was used to yield a-tocotrienyl acetatel (20, 65% de) which was subsequently hydrogenated to 19b in the presence of the catalyst 21. [11] The conversion of hydroquinone precursors such as 17 to chromanols gave surprisingly high de values given the fact that the flexibly attached dipeptide is the only chirality inducing unit. To a certain extent this result validates the proposal that in the active site of tocopherol cyclase a high energy conformer of the phytylhydroquinone can cyclize even in the presence of weak acids.
Organocatalytic Keysteps for the Synthesis of Chromanols
Organocatalysis Using Chiral Dioxetans
The retrosynthetic plan of this approach to a-tocopherol (1) is depicted in Scheme 5. The sequence poses two problems: i) enantioselective epoxidation of a triply substituted double bond lacking adjacent functionalization, see 22, and ii) regioselective, 'anti-Baldwin' ring opening of the epoxide 23 to form the 6-membered chromane system 24 without racemization.
Regarding enantioselective epoxidation we considered the application of organocatalysts developed by Zhao and Shi. [13] This group has reported that fructose-derived compounds such as 25 (+ H 2 O 2 ) cata- lyze the formation of chiral epoxides provided the olefin contains groups R 3 and R 4 that are very different in size (Scheme 6). In principle this is not the case for olefin 22 as both groups adjacent to the double are CH 2 . Nevertheless, we believed we could optimize the substrate through the substituents at the hydroquinone. Screening substrates with nine variations for R 1 / R 2 we found one outstanding result for 26 which gave epoxide 27 in 81% yield and 97% de (Scheme 7).
In order to accomplish the formation of the chromane system under inversion of configuration we first used conditions reported by Vilotijevic and Jamison [14] which favored pyran products in MeOH. However, a mono-protected epoxyphytyl hydroquinone gave exclusively the furan product following Baldwin's rule. [15] A systematic investigation (21 experiments) of the epoxide ring opening finally revealed that the epoxide 28 could be cyclized in acetonitrile/2M HCl-ether to the 3-hydroxy chromane 29 in 79% yield (Scheme 8). Removal of the hydroxyl group went smoothly through the corresponding tosylate, easily eliminated Scheme5.Retrosynthesisinordertoobtainchiralchromanolsviaregioselectiveepoxidering opening. and directly hydrogenated to afford 30 in almost quantitative yield and 93% de. Note that the small decrease of de from 27 to 30 is due to the extent of carbenium ion formation during the conversion of 28 to 29. Deprotection of 30 to 1 was accomplished by means of BF 3 . SMe 2 /AlCl 3 without epimerization at C(2).
Organocatalysis Using Proline Derivatives
In recent years organocatalysts derived from proline have been successfully applied for aldol and Mannich reactions. [16] We considered that a domino-aldol-oxaMichael reaction between phytal 31 and salicylaldehyde 32 catalyzed by 33 for example would either give aldehyde 34 or lactol 35 or a mixture of both (Scheme 9). From both intermediates one could envisage preparing a-tocopherol (1) by removal of the OH and CHO substituents at the heterocycle. Screening of ten different proline organocatalysts for the reaction between 31 and 32 revealed that 36 (Scheme 10) was the best choice to obtain lactol 35 in 60% yield and 97% de; the enantiomer of 36 gave the diasteromeric lactol. [17] The lactol 35 was oxidized to the benzylic lactone 37 which was readily hydrogenated to afford the acid 38. Only two further steps, i.e. removal of one carbon and demethylation, are required to convert the key intermediate 38 into a-tocopherol (Scheme 10). However conditions had to be carefully tuned to prevent racemization at C(2) due to thermal or acid-catalyzed ring opening/ring closure of the chromane system. Finally two procedures were found for the chain cleavage at C(2). Reduction of the acid 38 followed by oxidation gave the aldehyde 39 in 75% yield. Subsequent Rh-catalyzed decarbonylation [18] furnished the tocopherol ether 30 in 80% yield, 93% de. The same compound was obtained from 38 in 72% yield, 94% de using a Barton decarboxylation procedure. [19] Ether cleavage was accomplished by treating 30 with BF 3 . Me 2 S/AlCl 3 ; a-tocopherol (1) was obtained in 84% yield under retention of configuration at C(2).
In summary, although the domino reaction requires rather high concentrations (30ml%) of the proline derivative 36 the stereoselectivity and diastereoselectivity of this step are excellent providing one of the shortest procedures to obtain natural a-tocopherol (1). This strategy provides a general access to other members of the vitamin E family and further to various natural products containing highly substituted, chiral chromanols [20] or xanthones. [21] 
Coupling of Phenols with the Side Chain Containing the Required Three Chiral Centers
Several earlier syntheses of vitamin E compounds reported the preparation of the chiral chromanol using side chains that contain already all chiral centers. [6] Our unprecedented approach [22] employed the chiral key intermediate 40 which was planned to react under Mitsunobu conditions with phenols 41 and 42 generating chiral phenolethers 43 and 44 that could be further elaborated for the preparation of 1 (Scheme 11). The a-hydroxyester 40 was chosen because model reactions revealed that replacement of the ester by CN, CH=CH 2 , CHO and propargyl substituents was unsatisfactory and gave <20% yield of phenol ethers.
Mitsunobu reaction of 40 with 41 or 42 gave phenol ethers 43 and 44 with complete inversion of configuration and 64% and 68% yield, respectively. As the thioketal 45 derived from 44 did not cyclize in the presence of nBuLi [23] the corresponding bis-sulfone 46 was prepared [24] that gave the chromane 47 in 98% yield on treatment with NaOMe. Reductive removal of the dithiane tetroxide moiety was achieved with excess lithium naphthalenide yielding tocopheryl methylether 30 in 86% yield and 94% de (Scheme 12).
Alternatively 43 was reduced to aldehyde 48 and subsequent Wittig reaction, hydroboration and oxidation gave aldehyde 49 that cyclized in the presence of TFA to furnish the chromene 50 in excellent yield (Scheme 13). Hydrogenation of 50 followed by deprotection gave a-tocopherol (1) displaying 94% de.
The key step of both pathways to a-tocopherol (1) is a carefully controlled Mitsunobu reaction that generates the required phenolether with high de. Consecutive ring closure to the chromane/chromene was accomplished by two different procedures without epimerization.
Conclusion
Using a phytylhydroquinone derivative that allows for diastereoselective aciddriven double bond activation we developed an enzyme-like formation of the chromanol unit of a-tocopherol. Subsequently we employed two organocatalytic reactions as key steps towards diastereoisomerically enriched 1, and further a Mitsunobu reaction was used coupling a suitable phenol with a chiral a-hydroxyester under complete inversion of configuration. Except for the biomimetic cyclization all other approaches gave 1 displaying de well above 90%. Scheme13.Chromanolringclosureviaelectrophilicaromatic substitution.
